Mental Health Clinics in Belleville, WI Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Foundations Counseling Center Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 619 River St Ste F, Belleville, WI 53508 Phone: 608-424-9100 Fax: 608-424-9099 |
News Archive
Study finds one mRNA vaccine dose after SARS-CoV-2 infection produces highest neutralizing antibody titers
Researchers investigated the neutralizing antibody response that different mRNA vaccines induce in both previously convalescent and SARS-CoV-2 naïve individuals.
AMGA honors Boehringer Ingelheim with Distinguished Corporate Partner Award
The American Medical Group Association announced today that it will present the AMGA Distinguished Corporate Partner Award on April 16 to Boehringer Ingelheim Pharmaceuticals at its 2011 Annual Conference, April 13-16 at the Gaylord National.
Genetically engineered immune cells appear to promote healing in mice infected with MS-like disease
Genetically engineered immune cells seem to promote healing in mice infected with a neurological disease similar to multiple sclerosis (MS), cleaning up lesions and allowing the mice to regain use of their legs and tails.
Flexible treatment delivery intervention in primary care reduces symptoms of anxiety: Study
An intervention in primary care settings that allowed a choice of cognitive behavior therapy, medication, or both, along with computer-assisted treatment support for patients with common anxiety disorders, resulted in greater improvement in anxiety symptoms and functional disability compared to usual care, according to a study in the May 19 issue of JAMA, a theme issue on mental health.
FDA: Randomized clinical trial necessary to better interpret Clolar's efficacy and safety in adult AML
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
› Verified 9 days ago